Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry-Reference-Cited by-同舟云学术

Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

Published:2023-09 Issue:9 Volume:11 Page:2732-2747
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Chen Wenjia,Tran Trung N.,Sadatsafavi Mohsen,Murray Ruth,Wong Nigel Chong Boon,Ali Nasloon,Ariti Con,Bulathsinhala Lakmini,Gil Esther Garcia,FitzGerald J. Mark,Alacqua Marianna,Al-Ahmad Mona,Altraja Alan,Al-Lehebi Riyad,Bhutani Mohit,Bjermer Leif,Bjerrum Anne-Sofie,Bourdin Arnaud,von Bülow Anna,Busby John,Canonica Giorgio Walter,Carter Victoria,Christoff George C.,Cosio Borja G.,Costello Richard W.,Fonseca João A.,Gibson Peter G.,Yoo Kwang-Ha,Heaney Liam G.,Heffler Enrico,Hew Mark,Hilberg Ole,Hoyte Flavia,Iwanaga Takashi,Jackson David J.,Jones Rupert C.,Koh Mariko Siyue,Kuna Piotr,Larenas-Linnemann Désirée,Lehmann Sverre,Lehtimäki Lauri,Lyu Juntao,Mahboub Bassam,Maspero Jorge,Menzies-Gow Andrew N.,Newell Anthony,Sirena Concetta,Papadopoulos Nikolaos G.,Papaioannou Andriana I.,Perez-de-Llano Luis,Perng (Steve) Diahn-Warng,Peters Matthew,Pfeffer Paul E.,Porsbjerg Celeste M.,Popov Todor A.,Rhee Chin Kook,Salvi Sundeep,Taillé Camille,Taube Christian,Torres-Duque Carlos A.,Ulrik Charlotte,Ra Seung-Won,Wang Eileen,Wechsler Michael E.,Price David B.^ORCID

Funder

AstraZeneca UK Limited

Optimum Patient Care

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference46 articles.

1. Global strategy for asthma management and prevention,2022

2. Defining phenotypes in asthma: a step towards personalized medicine;Chung;Drugs,2014

3. Persistent variations in national asthma mortality, hospital admissions and prevalence by socioeconomic status and region in England;Gupta;Thorax,2018

4. Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population;Kerkhof;Thorax,2018

5. Characterization of severe asthma worldwide: data from the International Severe Asthma Registry (ISAR);Wang;Chest,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of biologics used in the treatment of asthma;Human Antibodies;2024-07-24

2. Expert consensus on oral corticosteroids stewardship for the treatment of severe asthma in the Middle East and Africa;Respiratory Medicine;2024-07

3. Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort;Allergy;2024-06-22

4. Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study;Journal of Clinical Medicine;2024-05-20

5. Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?;Pragmatic and Observational Research;2024-03